GO
Loading...

Actavis CEO: Continue Seeking Opportunities In Emerging Markets

Thursday, 24 Jan 2013 | 3:39 PM ET

Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.